FDA clearance lifts TEM
Tempus AI is climbing moderately on low volatility after receiving FDA clearance for its ECG-MR heart valve AI product, a positive but incremental regulatory win that traders are pricing in calmly rather than chasing.
Sources: https://markets.ft.com/data/announce/detail?dockey=600-202609280800BIZWIRE_USPRX____20260928_BW106625-1, https://www.investing.com/n
Sources
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works